Researchers identify promising cancer drug target in prostate tumors

Scientists at Dana-Farber Cancer Institute report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they describe as a “powerhouse” that drives runaway cell growth.

They said that drugs are on their way to clinical testing, but is hard to predict when they might become available for clinical testing.